Neurovascular Market Set to Reach Unprecedented Heights by 2028

According to a new report published by Allied Market Research, Neurovascular Market, Neurovascular disease is a condition caused to nervous tissues vascular structure, neurons and blood vessels that leads to serious brain damages such as stroke, and cerebral hemorrhage. The global market for central nervous system disease was accounted to approximately $78 billion in 2010.

Request Sample Copy of Report: https://www.alliedmarketresearch.com/request-toc-and-sample/2119

According to University of California, San Francisco (USCF), there are approximately 600,000 people suffering from stroke, out of which 10% are recovered. Almost 30% patients die due to stroke, and 60% of the patients remain disabled. The cost of care for these 60% patients accounted to approximately $8 billion. Cost of neurological disease treatment is lowering the growth for neurological disease. Companies are conducting clinical trials to commercialized cost effective therapies through mergers and acquisitions.

Key Takeaways:

Rapid Growth: The neurovascular market has experienced significant growth in recent years, driven by an increasing prevalence of neurovascular disorders, such as stroke and aneurysms.

Technological Advancements: Innovations in neurovascular devices and minimally invasive procedures have expanded treatment options and improved patient outcomes.

Growing Aging Population: The aging global population is a major demographic driver, as older individuals are more susceptible to neurovascular conditions, increasing the demand for neurovascular interventions.

Emerging Markets: Developing regions, particularly in Asia-Pacific, are witnessing robust growth due to improving healthcare infrastructure and rising awareness of neurovascular disorders.

Collaborative Research: Collaborations between healthcare institutions, research organizations, and industry players are driving research and development efforts, leading to new treatments and devices.

Regulatory Oversight: Stringent regulatory requirements and quality standards are shaping the market landscape, ensuring the safety and efficacy of neurovascular interventions.

Competition: The neurovascular market is competitive, with established players and new entrants vying for market share, resulting in continuous innovation and product development.

Personalized Medicine: Personalized treatment approaches, based on patient-specific factors, are gaining prominence, enhancing the precision of neurovascular interventions.

Key Benefits :

Key developmental strategies adopted by top market players engaged in this business, so that companies involved in development of neurovascular device can get competitive intelligence of their competitors

Market estimation for therapeutic devices and geographic segment is derived from current market scenario and expected market trends

Market attractiveness analysis has been included for various product segments, therapeutics, devices and geographic regions with detailed analysis of factors responsible for rapid growth of the market segments

In depth analysis of key market drivers, restraints and opportunities of non-invasive diagnostic market with impact analysis

Value chain analysis, Porter's five force model, top investment pockets (GE9 Cell Matrix) are analyzed and presented in detail in the report so that the decision makers receive clear picture of neurovascular disease treatment market

For Purchase Enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/100

Competitive Landscape:

Johnson & Johnson (Micrus)

Abbott Laboratories

Bayer AG

Boston Scientific Corporation

Chestnut Medical Technologies, Inc.

Johnson & Johnson

ITGI Medical Ltd.

Market Segments:
By THERAPEUTICS:

Endovascular cerebral aneurysm

Intracranial atherosclerotic disease

Chronic ischemic stroke

Acute ischemic stroke

By DEVICES:

Neurovascular liquid embolism

Intracranial stents & flow diverting devices

Neurovascular embolic coils

Carotid stents & embolic protection devices

Neurovascular thrombectomy devices

Market By Geography:

North America

Europe

Asia-Pacific

LAMEA

Obtain Report Details:

https://www.alliedmarketresearch.com/neurovascular-market

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Life Science Market: https://www.alliedmarketresearch.com/reports-store/life-sciences
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research

About Us:

Allied Market Research is market research, consulting, and advisory firm of Allied Analytics LLP. Founded in 2013, the firm has been instrumental in offering high-quality syndicated and customized market research reports, consulting services, and useful insights to leading market players, startups, investors, and stakeholders. Driven by the aim to eliminate sub-standard data and become a successful partner for organizations, Allied Market Research has been innovating continuously, expanding the product & service portfolio, and implementing the client-first approach since its inception. With the clientele spanning more than 7,000 organizations that also include a majority of Fortune 500 companies, AMR has a proven track record of helping and serving the global clientele and playing a major role in their success.

AMR is always focused on adhering to its core values such as quality, reliability, compliance, integrity, and value addition. The firm is striding forward with an endeavor to achieve success for its clients and an objective to become one of the leading firms in the market research industry.

This release was published on openPR.